GSEP
CARM

Golden State Equity Partners’s Carisma Therapeutics CARM Stock Holding History

Golden State Equity Partners’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6 Buy
+200
New +$6 ﹤0.01% 2018

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Golden State Equity Partners's CARM Position: Q1 2026 in Review

Golden State Equity Partners opened a new position in Carisma Therapeutics (CARM) in Q1 2026: 200 shares worth $6. The stake represents ﹤0.01% of the portfolio and ranks #2018 among its holdings.

3 funds tracked by Wall St. Rank hold CARM as of Q1 2026.

  • Golden State Equity Partners held 200 shares of Carisma Therapeutics worth $6 as of Q1 2026.
  • Carisma Therapeutics was a new Golden State Equity Partners position in Q1 2026.
  • Carisma Therapeutics made up ﹤0.01% of Golden State Equity Partners's portfolio in Q1 2026, its #2018 holding.
  • 3 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2026.

Based on Golden State Equity Partners's 13F filing for Q1 2026, filed 28 Apr 2026.